Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 435, 1008-1009 (23 June 2005) | doi:10.1038/4351008a; Published online 22 June 2005
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
- More Challenges
- Powered by:
nature jobs
Assistant Editor - Nature Methods
- Nature Publishing Group
- New York, NY
Assistant / Associate
- University of Missouri
- Columbia MO 65211 United States
Drug targeting: is race enough?
Meredith Wadman
Abstract
Pharmaceutical firms urged to look beyond race as first 'Personalized' drug is approved
The expected approval in the United States of the first drug targeted to a specific racial group is sparking debate about the future of 'personalized' medicine.Enthusiasts predict a future in which people are given genetic tests to help choose the drug to which they will respond best.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
